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Abstract
Background: Payers and regulatory bodies are increasingly placing emphasis on cost containment,
quality/outcome measurement and transparent reporting. Significant cost variation occurs in many
operative procedures without a clear relationship with outcomes. Clear cost-benefit associations will
be necessary to justify expenditures in the era of bundled payment structures.
Methods: All laparoscopic cholecystectomies (LCCKs) performed within a single health system over a
1-year period were analysed for operating room (OR) supply cost. The cost was correlated with Ameri-
can College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) outcomes.
Results: From July 2013 to June 2014, 2178 LCCKs were performed by 55 surgeons at seven hospitals.
The median case OR supply cost was $513  156. There was variation in cost between individual surgeons
and within an individual surgeon’s practice. There was no correlation between cost and ACS NSQIP out-
comes. The majority of cost variation was explained by selection of trocar and clip applier constructs.
Conclusions: Significant case OR cost variation is present in LCCK across a single health system,
and there is no clear association between increased cost and NSQIP outcomes. Placed within the lar-
ger context of overall cost, the opportunity exists for improved resource utilization with no obvious risk
for a reduction in the quality of care.
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Introduction
A major shift in the reimbursement mechanisms for healthcare
expenditures in the last decade has been driven by a combina-
tion of legislation, media, and efforts of insurance companies
and healthcare providers. The Medicare Prescription Drug,
Improvement, and Modernization Act in 2003 introduced the
Acute Care Episode Demonstration, a programme designed to
challenge current fee-based payment systems that reward
‘quantity of services provided, rather than quality of care’.1
Five hospitals or healthcare systems participated and received
global payments for all inpatient components of cardiothoracic
or orthopaedic procedures over a 3-year period. With a goal of
improving ’both the efficiency and quality of care provided to
Medicare beneficiaries’, millions of dollars were saved without
negatively impacting outcomes.2,3 The success of this pro-
gramme inspired further extensions of bundled payments,
which achieved slowed growth of health care spending while
improving outcomes.4,5 The Center for Medicare & Medicaid
Innovation’s Bundled Payments for Care Improvement Initia-
tive is the most recent, current and nation-wide project.6
The success of these programmes hinges on monitoring cost
while maintaining high-quality care and preventing adverse out-
comes. The interplay between cost and outcomes has been uni-
ted by a popular term in this field: value. The value in healthcare
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has been defined as healthcare outcome per dollar spent,7 with
an emphasis on beneficial outcomes. The study of outcomes has
grown with large well-established reporting datasets, including
the National Surgical Quality Improvement Program sponsored
by the American College of Surgeons (ACS NSQIP). This dataset
has been used as one component in studies examining complica-
tions in relation to the overall cost of procedures and post-oper-
ative management of patients, and has been used to study the
concept of value among hospitals delivering cost-effective care
while maintaining positive outcomes.8
The delivery of cost-effective care demands aggressive cost
containment. Variability in the delivery of care has been shown
to be the top source of excessive spending.9 Within the field of
surgery, operating room and supply costs have been shown to
comprise large portions of a procedural hospitalization
charge.10 Common procedures with standardized operative
approaches present a relatively controlled environment for the
study of variability at a specific level. A cholecystectomy is one
of the most common and familiar procedures for the general
surgeon or hepatobiliary specialist, with over 700 000 proce-
dures performed annually.11 Operating room (OR) and supply
cost for inpatient cholecystectomy in Medicare patients repre-
sent the second- and third-largest component of total hospital
charges at more than $3000 and $2000, respectively.10 Our
group hypothesized that, using a robust internal data collection
system for a common standardized procedure and comparing
cost to outcomes utilizing ACS NSQIP data, we could identify
intra-operative and surgeon-specific sources of variation in
laparoscopic cholecystectomy and thus could develop strategies
of cost-containment while maintaining quality.
Materials and methods
A retrospective review of laparoscopic cholecystectomy case costs
from OR records within a multi-hospital healthcare system was
performed for cases in the 12-month period July 2013 to June
2014. Included procedures were limited to laparoscopic chole-
cystectomy and laparoscopic cholecystectomy with an intra-op-
erative cholangiogram. Excluded procedures were any
laparoscopic cholecystectomy converted to a laparotomy or dur-
ing which any additional procedure was billed. Administrative
data from seven hospitals, all serving populations >50 000, were
used to determine intra-operative supply cost, defined as the
estimated acquisition cost for instruments on the surgical field as
recorded in the intra-operative electronic case log by an OR
nurse. This cost is exclusive of charges for anaesthesia supplies,
radiology support for cholangiograms and physician or facility
fees. The estimated cost was used instead of the exact cost to
account for inter-facility differences and the impact of purchas-
ing agreements including tiered pricing, incentives and rebates.
Comparative outcomes data for surgeons and institutions were
obtained using cases that met the above inclusion criteria and
were included within the ACS NSQIP during 2012 and 2013.
Five of the seven examined hospitals participated in ACS NSQIP
during this interval. References to the complication rate pertain
to any one or more standard ACS NSQIP-specified postoperative
complications occurring in the 30-day post-procedure period for
a patient, as per standard ACS NSQIP program protocol. Note
that cost assessments and quality assessments were not matched
on a case-by-case basis but were instead derived from separate
but overlapping 12-month periods with robust data for either
cost or complications.
Results
A total of 2178 laparoscopic cholecystectomies were performed
by 55 surgeons at seven hospitals during the 12-month review
period July 2013 to June 2014. The total intra-operative supply
cost for the seven hospitals was $1 169 000 (mean $537/case).
The grand median case supply cost was $513, with some vari-
ability in median per hospital cost as well as full case distribu-
tion per hospital (Fig. 1). Surgeon-specific expenditure
demonstrated variability both across and within a surgeon’s
practice, without any correlation to case volume (Fig. 2).
The overall ACS NSQIP ’any ’ complication rate for laparo-
scopic cholecystectomies at our hospitals was 3%; the average
nationwide ACS NSQIP complication rate for the same period
and procedure types was 3.5%. Surgeon expenditure relative to
outcomes failed to demonstrate any association (Fig. 3). Sur-
geons who have median costs lower than the healthcare system
median of $513 with operative outcomes lower than the health-
care system average of 3% would be considered ’high-value’ sur-
geons, whereas those with cost and outcomes above these
benchmarks would be considered ‘low-value’ surgeons.
Of the total operative supply costs, the largest charges came
from three categories of disposable items: laparoscopic trocar
bundles (33.4%), packs and drapes (26.8%), and clip appliers
(16%). Packs and drapes are largely standardized across this
health system’s ORs, but the stock and utilization of laparo-
scopic trocar bundles and clip appliers exhibited great variation.
Laparoscopic trocar bundles consisting of one 10- to 12-mm
umbilical port and three 5-mm ports are offered from three
different manufacturers with costs differing as much as $138.
Disposable clip appliers are available from two manufacturers,
with variation in the price of a few dollars for 10-mm clip appli-
ers and $60 for 5-mm clip appliers. The most expensive 5-mm
clip applier was used 781 times in the review period, and the less
expensive 5-mm clip applier was used 500 times in the same
period. The most expensive 10-mm clip was used 670 times and
the less expensive 10-mm clip was used 231 times.
Finally, using a line-item analysis comparing low-cost to
high-cost laparoscopic cholecystectomies, it was determined
that inclusion of an intra-operative cholangiogram was not a
significant contributor to excess cost but is a significant con-
tributor to cost variation, with cholangiogram-specific supply
cost ranging from $18 to over $150.
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Discussion
A seemingly endless number of sources of variation exist
within a single operative and post-operative hospitalization,
but one that is most intimately and actively controlled by
surgeons is the intra-operative supply cost. We have demon-
strated that intra-operative cost, particularly through the
expense of disposable items such as trocar sets and clip appli-
ers, varies greatly among surgeons and have presented a data
set that failed to identify a relationship between cost, case vol-
ume and observed ACS NSQIP outcomes. The purpose of this
Figure 2 Intra-operative supply cost variability among surgeons. Each dot represents one surgeon. Dot colour represents one specific
hospital. Dot size corresponds to case volume per surgeon. Intra-operative supply cost varies across surgeons and within a single
surgeon’s practice (y-axis ‘standard deviation’) for both high- and low-volume surgeons
Figure 1 Intra-operative supply cost per case. The distribution of case costs for each of seven hospitals is outlined by row. Box plots
depict 25th percentile, median and 75th percentile. Whiskers represent 1.59 interquartile (IQR), and dots represent high outliers. The
system median cost of $513 is depicted as a dotted vertical line. Hospitals are sorted by case volume in the period as per the numbers
in the first column. Investigation of high outlier cases identified the use of energy devices as a common cause of high case cost
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study was to identify, within our single healthcare system,
sources of cost variability to develop affordable, streamlined
systems for intra-operative cost containment while maintaining
quality. The data herein have been presented to working
groups including the individuals surgeons included in the
study, who now know where their cost and performance
assessment, and thus are given some sense of their ‘value’, rela-
tive to others (as shown in Fig. 3). The initial reception by our
surgeons to this data was favourable and, in early follow-up,
some resource-favourable practices have been observed. The
metric of value is expected to be a key component of referral
and reimbursement methods from insurers, with legislation
requiring a value-based payment modifier for Medicare reim-
bursement set to go into effect in 2015, with extension to all
physicians by 2017.12
The first anticipated outcome of this study was to stimulate
discussion regarding the cost of and options associated with
intra-operative supplies. Disposables were the leading source of
cost variability and have previously been the target of cost-
saving strategies in a laparoscopic appendectomy.13 With this
approach, we can release to each surgeon not only their total
case volume and associated costs, but also the exact number of
times they used a disposable item and how much that item
costs. Intra-operative bar codes displaying cost are fixed to
each disposable item, with the intent to educate surgeons and
OR staff of these costs at the time of opening the item. Inter-
ventions to educate surgeons on intra-operative supply cost
and cost-effective alternatives in a laparoscopic cholecystec-
tomy have reduced cost by 10% in a recent study.14
Our second goal was to optimize intra-operative supply
utilization by monitoring intra-operative utilization variability.
Demonstrating that spending has no evident association with
outcomes should allow us contemplation of these issues with-
out raising concern for risking adverse outcomes. For example,
these data demonstrate that our surgeons are frequently select-
ing the most expensive model of both 5- and 10-mm clip
appliers. If surgeons instead selected the less expensive manu-
facturer in each size, this would have saved 4% of the entire
laparoscopic cholecystectomy budget, over $52 000, in
12 months. Resource utilization interventions planned include
standardization of instrument sets, which have been shown to
result in a cost reduction as high as 20% in a laparoscopic
appendectomy.15
Finally, we are using this same analytic approach to study
cost reduction strategies for other types of surgical cases,
including laparoscopic colectomies and the associated variabil-
ity in the utilization of available stapling devices.
In maximizing value, the hospital and the surgeon would be
expected to benefit in a bundled payment system, ideally with-
out compromising the care of the patient. Unfortunately, this
drive towards resource preservation has several associated con-
siderations that could threaten its success. The first is that sur-
geons might be convinced that using familiar instruments – or
not being restricted to the use of alternative lower-cost instru-
ments – is safer and results in quicker surgeries, and there is
every reason to believe that this should be true. Our current
study excluded the many costs associated with operating room
time and thus is unable to address this idea. As we study the
Figure 3 Surgeon-specific median expenditure versus any National Surgical Quality Improvement Program (NSQIP) adverse events.
Surgeon expenditure is compared with the health system complication rate (‘average rate’ = 3%) and the national American College of
Surgeons (ACS) NSQIP complication rate (‘NSQIP rate’ = 3.5%) during the study period. The area of circles represents surgeon case
volume and colour represents hospital affiliation. There is no obvious negative or positive correlation between cost and outcomes
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impact of cost-conscious practices and interventions, we will
carefully consider and explore the limitations of surgeon pref-
erence and stances towards resource stewardship. A second
concern is that the current reimbursement model does not
adequately support a system in which cost-conscious surgeons
are rewarded. Savings are primarily realized by hospitals or
payers; cost savings do not necessarily return to the surgeon
who created them. The motivation for using a lower-cost clip
applier, at least at this stage, must instead be primarily based
on an obligation to be responsible resource stewards for a soci-
ety without compromising patient care. Alternative payment
mechanisms that can directly reward surgeons for resource
stewardship are growing but not yet widespread. Finally, we
must be careful when promoting increasing value through con-
trolling resource utilization; in doing so, we must always guard
against unintended effects or unsafe practices. Surgeons may
become more risk averse, refusing to care for patients whose
pathophysiology or comorbidities are such that even adjusted
reimbursement are not likely to cover the anticipated cost of
an expectedly complicated surgery 16 or, alternatively, surgeons
may remain motivated by preference or patient satisfaction to
offer surgeries with advanced yet more expensive equipment
(i.e. smaller instruments, robotic procedures, etc.).
Limitations of this study should be mentioned. The first is
that the cost and quality data were not matched case by case.
Both internal cost and outcome ACS NSQIP data were col-
lected from separate but overlapping 12-month periods as
these time periods were the most recent available data for each
data source and thus were used to present the most recent
insights. Despite this, this study is the largest for laparoscopic
cholecystectomy intraoperative cost and the only one utilizing
ACS NSQIP data. An additional limitation is that we did not
establish a system to adjust for a surgeon’s ‘value’ based on the
complexity of his or her patients. We believe that patient-
specific complexity is likely to have more of an impact on OR
time and post-operative care, which are excluded from the pre-
sent study. This is an area of ongoing investigation beyond the
scope of this current work. Exclusions of complex case types
from this current work also help to standardize against extre-
mely complex cases.
Conclusion
Intra-operative supply cost for a laparoscopic cholecystectomy
varies greatly among surgeons and does not correlate with
ACS NSQIP outcomes. Variability from supply cost is largely
observed in the use of disposable items including trocar sets
and clips. Resource stewardship has become a clear and pre-
sent obligation for our profession, and these results present
opportunities to increase value by reducing variability and
reducing cost while maintaining outcome quality for our
patients.
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